Manufacturing News of Note—Olon starts new facility; Hikma signs on with Civic Rx

stocks
(Pixabay)

> Italy-based CDMO Olon has started construction of new manufacturing facility at its microbial CDMO facility located in Capua, Italy. Release

> Hikma Pharmaceuticals has become the latest CDMO to sign a deal with Civica Rx, the hospital-controlled company that is helping healthcare providers get drugs that are often in short supply. Release

> WuXi STA says its Analytical Service Unit in Shanghai and active pharmaceutical ingredient process R&D and manufacturing facility in Changzhou both successfully passed two inspections from the U.S. FDA. Release

> The CPhI and P-MEC China trade show in China saw record numbers, reflecting the surge of interest in manufacturing products in that country. Release 

 

 

Suggested Articles

GBA offers Brexit escape, Merck and Just - Evotech to share production space, GSK ointment line in Bangladesh may reopen and more news of note.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.